Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair

Mutation Research
Ann-Sofie GustafssonBo Stenerlöw

Abstract

Efficient and correct repair of DNA double-strand break (DSB) is critical for cell survival. Defects in the DNA repair may lead to cell death, genomic instability and development of cancer. The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is an essential component of the non-homologous end joining (NHEJ) which is the major DSB repair pathway in mammalian cells. In the present study, by using siRNA against DNA-PKcs in four human cell lines, we examined how low levels of DNA-PKcs affected cellular response to ionizing radiation. Decrease of DNA-PKcs levels by 80-95%, induced by siRNA treatment, lead to extreme radiosensitivity, similar to that seen in cells completely lacking DNA-PKcs and low levels of DNA-PKcs promoted cell accumulation in G2/M phase after irradiation and blocked progression of mitosis. Surprisingly, low levels of DNA-PKcs did not affect the repair capacity and the removal of 53BP1 or γ-H2AX foci and rejoining of DSB appeared normal. This was in strong contrast to cells completely lacking DNA-PKcs and cells treated with the DNA-PKcs inhibitor NU7441, in which DSB repair were severely compromised. This suggests that there are different mechanisms by which loss of DNA-PKcs functions can sensitize c...Continue Reading

References

Apr 27, 2001·Carcinogenesis·D H AuckleyS A Belinsky
Jul 9, 2003·Immunological Reviews·Kevin D MillsFrederick W Alt
Sep 25, 2003·Nature Reviews. Molecular Cell Biology·Michael R LieberKlaus Schwarz
Jan 17, 2004·Biochimie·S P Lees-Miller, K Meek
Jan 29, 2005·The Journal of Biological Chemistry·Benjamin P C ChenDavid J Chen
Jan 29, 2005·The EMBO Journal·Ana-Maria DragoiWen-Ming Chu
Jul 21, 2005·International Journal of Radiation Oncology, Biology, Physics·Sang-Wook LeeEunsil Yu
Jul 11, 2006·DNA Repair·Sandeep BurmaDavid J Chen
Dec 16, 2006·Journal of Cellular Biochemistry·Suisheng ZhangFrank Grosse
Dec 25, 2007·Cell Research·Meena ShrivastavJac A Nickoloff
Feb 27, 2009·Cancer Research·Eli S WilliamsSusan M Bailey
Feb 19, 2011·The Journal of Biological Chemistry·Kyung-Jong LeeBenjamin P C Chen
Apr 29, 2011·Critical Reviews in Biochemistry and Molecular Biology·Dorothee DeckbarMarkus Löbrich
Jun 16, 2011·Cell Cycle·Eric J Gapud, Barry P Sleckman
Oct 20, 2011·Molecular Cancer Research : MCR·Arun AzadBenjamin Solomon
Jan 11, 2012·Mutation Research. Reviews in Mutation Research·M MartínA Genescà
Oct 31, 2012·Pharmacology & Therapeutics·John M Furgason, El Mustapha Bahassi
Feb 7, 2013·Frontiers in Pharmacology·David DavidsonRaquel Aloyz
Jul 31, 2013·Swiss Medical Weekly·Daniela HühnAlessandro A Sartori
Aug 8, 2013·DNA Repair·Anastas Gospodinov, Zdenko Herceg
Oct 30, 2013·Journal of Cellular Biochemistry·Bo HuangPing-Kun Zhou
Dec 24, 2013·The British Journal of Radiology·A Kakarougkas, P A Jeggo

❮ Previous
Next ❯

Citations

Jan 14, 2020·Genetics and Molecular Biology·Juliana Ferreira de SousaValeria Valente

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis